A Receptacle for supporting, rotating and sculpting a portion of ice cream or similarly malleable food while it is being consumed.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6416972 | DNA encoding a prostaglandin F2 receptor, a host cell transformed therewith and an expression product thereof Molecular cloning and expression of a prostaglandin F2 receptor which is linked to the signal transduction pathways via guanine nucleotide binding regulatory (G) proteins and measured by, for example, cAMP, IP3 or intracellular calcium. ... | 07/09/2002 |
| 6187813 | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega cha... | 02/13/2001 |
| 6150342 | Heparin derivatives for treatment of angina pectoris The invention relates to new heparin derivatives from bovine or porcine heparin which have a molecular weight equal to or larger than the standard heparin, show a sulfur content which is equal to or higher than that of the starting heparin or at least 13%... | 11/21/2000 |
| 6054421 | Medical emulsion lubricant A medical lubricant suitable for injection into the blood stream of a patient. The lubricant is suitable for use with rotating equipment such as atherectomy drive shafts moving within sheaths and over guide wires. The lubricant is an oil-in-water emulsion... | 04/25/2000 |
| 6042571 | Injection device An injection device comprising a) a housing, b) a cartridge containing a preparation or precursor components for the preparation and having a front part and a rear part defining a general cartridge axis, an outlet for the preparation arranged at the front... | 03/28/2000 |
| 6030999 | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega cha... | 02/29/2000 |
| 6004298 | Injection devices A piston rod for use in an injection device for an injection cartridge is provided with a single or multiple thread along a predetermined portion of its length, after which the thread changes into a longitudinal groove for each thread, such that a turning... | 12/21/1999 |
| 5972885 | Method for treatment of hemophilia by extravascular administration of factor VIII deletion derivatives A pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising recombinant coagulation factor VIII and use thereof for manufacture of a medicament for treating haemophilia is provided. The formulation comprises a hig... | 10/26/1999 |
| 5962650 | Oxygen-reduced aqueous solution of factor VIII The present invention relates to a final drug product comprising coagulation factor VIII in an aqueous solution with a reduced concentration of oxygen. In this way, the factor VIII activity can be retained during storage to a surprisingly high degree. The... | 10/05/1999 |
| 5952005 | Controlled release preparation for administering morphine An oral pharmaceutical preparation containing a therapeutically effective amount of a salt of morphine for administration once daily is provided. The preparation contains particles which have a core containing a salt of morphine coated with a barrier laye... | 09/14/1999 |
| 5919766 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer The present invention relates to a novel composition comprising coagulation Factor VIII and a non-ionic surfactant such as block co-polymers, e.g. polyoxamers or polyoxyethylene (20) fatty acid esters e.g. polysorbate 20 or polysorbate 80 as a stabilizer.... | 07/06/1999 |
| 5902788 | Insulin-like growth factor II as antitumour agent The invention relates to the use of IGF-II for the manufacture of a medicament for the treatment of tumours, and especially for the manufacture of a medicament for growth inhibition of melanoma cells and for the treatment of cutaneous melanomas. The medic... | 05/11/1999 |
| 5888815 | Cell cultivation method and medium The invention relates to a method of cultivating mammalian cells expressing recombinant Factor VIII in a serum-free cell culture medium of the type that normally requires the presence of human serum albumin (HSA) and which is substantially free from fatty... | 03/30/1999 |
| 5880098 | Therapeutic treatment The present invention is directed to a therapy involving administering effective amounts of an organic osmolyte selected from the group consisting of polyols, amino acids and methyl amines, that regulate hydration of certain cells, for treating or prevent... | 03/09/1999 |
| 5876968 | Dimer of molecular variant of apolipoprotein and processes for the production thereof Substantially pure dimers of Apolipoprotein Al-Milano (Al-M/APO Al-M) isolated and characterized from plasma are provided. Pharmaceutical compositions comprising the Apo Al-M/Apo Al-M are also provided. Apolipoprotein Al-M dimer can be produced in a recom... | 03/02/1999 |
| 5872097 | Oligopeptides with affinity to opioid receptors Straight or cyclic pentapeptides with receptor affinity to μ or δ opioid receptors having a primary sequence backbone of Tyr-X-Phe-Leu-Z, Seq. ID Nos. 1, 2, and 3. X and Z can be covalently coupled to provide a heterocyclic structure according to the fo... | 02/16/1999 |
| 5831012 | Bacterial receptor structures Novel proteins obtainable by mutagenesis of surface-exposed amino acids of domains of natural bacterial receptors, said proteins being obtained without substantial loss of basic structure and stability of said natural bacterial receptors; proteins which h... | 11/03/1998 |
| 5817055 | Dual-chamber injection cartridge An injection cartridge of the dual-chamber type, which comprises a cylindrical cartridge barrel having a front chamber for a solid product and a rear chamber for a liquid product. The chambers are sealingly separated by a displaceable piston of a resilien... | 10/06/1998 |
| 5817765 | Purification of plasma proteins Virus inactivating chemicals and/or detergents in an aqueous composition containing a water-soluble plasma protein are reduced by selecting a suitable combination of temperature and concentration above 0.5M of salt with a high salting out effect according... | 10/06/1998 |
| 5810778 | Apparatus for controlled delivery of liquids An apparatus for a controlled delivery of a liquid preparation from a cylindrical liquid container, which has a liquid outlet at its front end and a movable wall, which acts like a piston at its rear end is provided. The driving force acting on the movabl... | 09/22/1998 |
| 5804217 | Manufacturing matrices Porous cellulose matrices with a defined particle size and a significantly higher porosity (i.e. pore volume) than conventional formulations, such as pellet formulations containing cellulose and binders are prepared. The cellulose is mechanically treated ... | 09/08/1998 |
| 5804550 | Peptide antagonists at glutamate and NMDA receptors The invention relates to the use of a new type of peptide antagonists at glutamate receptors and a subtype of glutamate receptors (NMDA (N-methyl-D-aspartate)) for the manufacture of a medicament to influence the glutamate receptor and the NMDA-receptor c... | 09/08/1998 |
| 5783560 | Use of human growth hormone for preoperative administration The invention relates to the use of growth hormone (GH) or effective analogues thereof for the manufacture of a medicament intended for preoperative administration in order to reduce protein loss, especially for the manufacture of a medicament for the pre... | 07/21/1998 |
| 5783559 | Solution containing IGF-1 The invention relates to solutions containing IGF-1 or any functional analogue thereof in which pH is 5.5 to 6.5, preferably 5.7 to 6.2. The amount of phosphate as buffer substance should be in a concentration of less than 50 mmol/L Preferably the formula... | 07/21/1998 |
| 5769824 | Apparatus for controlled delivery of liquids An apparatus for controlled delivery of a liquid consists of a delivery unit which comprises a liquid container (3) having at least one movable wall (12) and a liquid outlet which is provided with a flow restriction, and a power unit which comprises a sec... | 06/23/1998 |
| 5750369 | DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof Molecular cloning and expression of a prostaglandin F2 receptor which is linked to the signal transduction pathways via guanine nucleotide binding regulatory (G) proteins and measured by, for example, cAMP, IP3 or intracellular calcium. ... | 05/12/1998 |
| 5747533 | Use of ω-3-fatty acids The present invention relates to omega-3-fatty acid containing preparations for the treatment of Disseminated Intravascular Coagulation (DIC) and symptoms related to DIC, as well as such preparations for reducing a pathological increase in pulmonary arter... | 05/05/1998 |
| 5743890 | Pistons for injection cartridges A piston (11) to be used in displacing a liquid inside a cylindrical chamber, such as in an injection cartridge of the dual-chamber type, has at least one of its end surfaces (12) shaped convex such that said end surface or surfaces (12) are essentially p... | 04/28/1998 |
| 5741566 | Autoclavable multilayer films An autoclavable multi-layer film formed of thermoplastic materials capable of being processed into hollow shapes and useful for packaging oxygen sensitive materials. The film includes sequential layers A--B--C--D--C--B'--A', wherein the film may optionall... | 04/21/1998 |
| 5735824 | Device for metering and administering a liquid preparation An injection device is provided for the infinitely variable metering and administering of a liquid preparation from a multi-dose injection cartridge having a rear piston which may be moved forward by means of a piston rod. The longitudinal movement of the... | 04/07/1998 |
| 5736515 | Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid A method for treatment of a patient for obtaining an increased concentration of a factor selected from the group consisting of growth hormone, insulin-like growth factor (IGF-I) and IGFBP-3 in cerebrospinal fluid by administration of growth hormone or ana... | 04/07/1998 |
| 5734026 | Process for manufacturing crystals of growth hormone and crystals thereby obtained A process for manufacturing crystals of growth hormone (GH) comprising the steps of: i) mixing GH with an aqueous solution comprising a buffer and a chemical compound with the general formula (1): Ar----CR1 R2 --!n----C R3 ... | 03/31/1998 |
| 5731346 | Use of omega-3-fatty acids The present invention relates to omega-3-fatty acid containing preparations for the treatment of Disseminated Intravascular Coagulation (DIC) and symptoms related to DIC, as well as such preparations for reducing a pathological increase in pulmonary arter... | 03/24/1998 |
| 5728075 | Injection devices A piston rod device for use in an injection device for an injection cartridge is provided with a single or multiple thread (3) along a predetermined portion of its length, after which the thread (3) changes into a longitudinal groove (5) for each thread, ... | 03/17/1998 |
| 5721114 | Expression system for producing apolipoprotein AI-M The invention relates to an expression system giving high extracellular production of apolipoprotein AI-M (Milano) using E. coli and comprises a plasmid carrying an origin of replication, an inducible promoter sequence, a DNA sequence coding for a signal ... | 02/24/1998 |
| 5716338 | Dual-chamber type injection cartridge with bypass connection An injection cartridge (1) of the dual-chamber type having a bypass connection (12) between its two chambers (9, 10) which is arranged such that the interior wall of the cartridge is modified in a predetermined area in such a way that the movable wall (11... | 02/10/1998 |
| 5714477 | Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters The present invention relates to pharmaceutical compositions containing heparin or heparin fragments or their derivatives in combination with one or more glycerol esters of at least one fatty acid as single absorption enhancer. The compositions are useful... | 02/03/1998 |
| 5710127 | Use of growth factor IGF-I and/or IGF-II The present invention relates to a composition comprising exogenous human or animal IGF-I or IGF-II or both or effective analogs thereof comprising foodstuff for oral administration wherein the foodstuff is selected from the group consisting of artificial... | 01/20/1998 |
| 5701937 | Fluid distribution system Provided is a closed fluid distribution system with manifold devices for aseptically distributing fluids in conduits from a controlled atmosphere zone for production of the fluids to collapsible storage containers located outside the zone. The manifold de... | 12/30/1997 |
| 5690943 | Storage of parenterally administerable products The present invention is directed to the method and use of a helium containing gas for improving the physical stability of packaged sensitive products, especially those products which contain a fat emulsion.... | 11/25/1997 |